About Lapatinib 250 Mg Tablet
Get Lapatinib 250 Mg Tablet at an unbeatable price from a preeminent exporter, supplier, and trader in India. Formidable in its fight against breast cancer, this prescription-only, film-coated oval tablet is designed for oral administration and holds the ATC Code L01XE07. Each bottle contains 30 tablets, with a long shelf life of 24 months. Add to Cart today to receive the benefit of a first-rate HER2 inhibitor, supported by an excellent track record from a leading pharmaceutical company in oncology care.
Lapatinib 250 Mg Tablet: Versatile Application Sites
Lapatinib 250 Mg Tablet is primarily indicated in oncology, notably for treating breast cancer as a HER2 inhibitor. The site of application is strictly oral, designed for direct ingestion under healthcare supervision. Apart from its formidable role in breast cancer therapy, ongoing clinical research explores other potential applications in related HER2-positive malignancies, making this tablet an excellent solution in advanced therapeutic regimens. Prescribed use is crucial to ensure optimal benefits and safety.
Easy Payment Terms and Seamless Delivery Worldwide
Purchase Lapatinib 250 Mg Tablet at a competitive list price with flexible payment terms tailored for bulk orders and regular clients. With efficient goods transport and quick dispatching, we ensure timely delivery to major export markets worldwide, including Asia, Africa, and the Middle East. Customers can rely on consistent stock availability and secure packaging to preserve product integrity during transit, enhancing convenience and reliability for all partners and buyers.
FAQ's of Lapatinib 250 Mg Tablet:
Q: How should Lapatinib 250 Mg Tablet be administered?
A: Lapatinib 250 Mg Tablet is administered orally. It is essential to follow the dosage and timing prescribed by your healthcare provider to achieve the best therapeutic outcome.
Q: What is the main benefit of using Lapatinib 250 Mg Tablet?
A: The primary benefit of Lapatinib 250 Mg Tablet is its effectiveness as a HER2 inhibitor in treating HER2-positive breast cancer, helping to slow or stop cancer cell growth.
Q: When is Lapatinib 250 Mg Tablet recommended for patients?
A: Lapatinib 250 Mg Tablet is recommended for patients diagnosed with HER2-positive breast cancer, particularly when other treatments are not suitable or as part of a combination therapy.
Q: Where can I purchase Lapatinib 250 Mg Tablet?
A: You can get Lapatinib 250 Mg Tablet through licensed pharmacies, leading exporters, suppliers, and trusted traders in India that require a valid prescription from a healthcare professional.
Q: What is the process for storing Lapatinib 250 Mg Tablet?
A: The tablets must be stored below 30C in their original bottle, away from moisture and direct sunlight, to maintain effectiveness and shelf life for up to 24 months.
Q: What are the physical characteristics of Lapatinib 250 Mg Tablet?
A: Each tablet is oval in shape, film-coated, and comes in a bottle containing 30 tablets designed for oral administration.